Large Cap / Pharmaceuticals, Biotechnology & Life Sciences
PFE Obtains FDA Approval for Lyrica

Pfizer FDA Approval Received

June 21, 2012

On June 21, 2012, Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved the use of Lyrica® (pregabalin) capsules CV for the management of neuropathic pain associated with spinal cord injury.

To view the full article, please subscribe or login.

Profit from The Turnaround Letter's...

  • Market-Beating Investment Results
  • 27+ Years of Turnaround Experience
  • Diverse Stock Picks for Today's Unpredictable Market

Distressed Investing Blog

Distressed Investing Blog

How Will the Recall Issue Affect GM Stock?

Because General Motors is currently the subject of many negative headlines arising from a significant recall relating to ignition switches, we wondered what long-term effect the recall would have on GM’s stock. Our best guess is “very little.” Read More.

Top Stock Picks for 2014

sample turnaround newsletter

 

 

Give your portfolio a boost with this FREE stock report!

 

The stock market continues to be ripe with great turnaround investment opportunities: the picks from last year’s report gained an average of 96%.

Current Total Returns

 

Value Stock Profit

Total returns cover the fulll year 2013.

Note: Returns are not adjusted for inflation.

 

Read More.

Sample Issue

TL Spotlight

 

Value Stock Picks

 

MoneyShow.com named George's stock pick top performer for all of 2013 and shared this feature interview to update investors on MTG's status and highlight select year-end bounce candidates.

 

Learn more.